09 Mar Uncategorized Eastgate Biotech Corp (OTC: ETBI) Management Interview March 9, 2022 By admin 0 comments Eastgate Biotech Corp (OTC: ETBI) Management Interview Interview with COO Bill Abajian Eastgate’s new COO took time...Continue reading
09 Mar Uncategorized EastGate Biotech Announces Appointment of Bill Abajian to Lead Licensing and Marketing Phase as Chief Operating Officer March 9, 2022 By admin 0 comments EastGate Biotech Announces Appointment of Bill Abajian to Lead Licensing and Marketing Phase as Chief Operating Officer WEST CALDWEL...Continue reading
09 Mar Uncategorized EastGate Biotech Files Application to Initiate Phase III clinical trial for Insugin March 9, 2022 By admin 0 comments Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan ...Continue reading
09 Mar Uncategorized Bill Abajian of EastGate Biotech Corp. to speak at the 2019 M&A Forum for Pharma, Biotech and Med Device to be held between August 12 – 14, 2019 in Philadelphia March 9, 2022 By admin 0 comments Forum to focus on Innovative Partnership Opportunities for Product, Portfolio and Market Development WEST CALDWELL, NJ...Continue reading
09 Mar Uncategorized EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 diabetes patients March 9, 2022 By admin 0 comments Multi-Center Phase III trial planned for 2019 WEST CALDWELL, NJ and TORONTO, ON /NEWMEDIAWIRE/ May 15, 2019/ Eastgate Biotech Co...Continue reading
09 Mar Uncategorized EastGate Biotech Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes March 9, 2022 By admin 0 comments Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a ...Continue reading
09 Mar Uncategorized Eastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin March 9, 2022 By admin 0 comments https://wallstreetanalyzer.com/2019/04/09/eastgate-biotech-corp-otcbb-etbi-interview-with-ceo-anna-gluskin/Continue reading
09 Mar Uncategorized Eastgate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply March 9, 2022 By admin 0 comments Alliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mout...Continue reading
09 Mar Uncategorized EastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships March 9, 2022 By admin 0 comments e both our JV partner and Bill represent Eastgate at the conference,” said Anna Gluskin CEO of Eastgate Biotech. “Not only can they sp...Continue reading
09 Mar Uncategorized EastGate Biotech Appoints Additional Consultants in Preparation of Progressing Company Developments in 2019 March 9, 2022 By admin 0 comments WEST CALDWELL, NJ and TORONTO, ON / ACCESSWIRE / December 17, 2018 / Eastgate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical comp...Continue reading